Shanghai Model Organisms Center Inc (688265) - Net Assets
Based on the latest financial reports, Shanghai Model Organisms Center Inc (688265) has net assets worth CN¥1.70 Billion CNY (≈ $249.07 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.90 Billion ≈ $277.91 Million USD) and total liabilities (CN¥197.12 Million ≈ $28.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688265 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.70 Billion |
| % of Total Assets | 89.62% |
| Annual Growth Rate | 44.25% |
| 5-Year Change | 560.18% |
| 10-Year Change | N/A |
| Growth Volatility | 183.99 |
Shanghai Model Organisms Center Inc - Net Assets Trend (2015–2024)
This chart illustrates how Shanghai Model Organisms Center Inc's net assets have evolved over time, based on quarterly financial data. Also explore Shanghai Model Organisms Center Inc assets under control for the complete picture of this company's asset base.
Annual Net Assets for Shanghai Model Organisms Center Inc (2015–2024)
The table below shows the annual net assets of Shanghai Model Organisms Center Inc from 2015 to 2024. For live valuation and market cap data, see 688265 market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.68 Billion ≈ $246.28 Million |
-3.10% |
| 2023-12-31 | CN¥1.74 Billion ≈ $254.15 Million |
-1.65% |
| 2022-12-31 | CN¥1.77 Billion ≈ $258.41 Million |
-0.99% |
| 2021-12-31 | CN¥1.78 Billion ≈ $261.01 Million |
+599.66% |
| 2020-12-31 | CN¥254.93 Million ≈ $37.30 Million |
+88.31% |
| 2019-12-31 | CN¥135.38 Million ≈ $19.81 Million |
+20.74% |
| 2018-12-31 | CN¥112.13 Million ≈ $16.41 Million |
+15.58% |
| 2017-12-31 | CN¥97.02 Million ≈ $14.20 Million |
-1.36% |
| 2016-12-31 | CN¥98.35 Million ≈ $14.39 Million |
+58.18% |
| 2015-12-31 | CN¥62.18 Million ≈ $9.10 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Model Organisms Center Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 520.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥81.26 Million | 4.83% |
| Common Stock | CN¥77.96 Million | 4.63% |
| Other Comprehensive Income | CN¥31.11 Million | 1.85% |
| Other Components | CN¥1.49 Billion | 88.69% |
| Total Equity | CN¥1.68 Billion | 100.00% |
Shanghai Model Organisms Center Inc Competitors by Market Cap
The table below lists competitors of Shanghai Model Organisms Center Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
SHE:002864
|
$471.23 Million |
|
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SHG:603976
|
$471.28 Million |
|
Qingdao Richmat Intelligence Technology Co. Ltd. A
SHE:301320
|
$471.42 Million |
|
Temple & Webster Group Ltd
AU:TPW
|
$471.47 Million |
|
Manitowoc Company Inc
NYSE:MTW
|
$471.05 Million |
|
Zhongtong Guomai Communication
SHG:603559
|
$470.93 Million |
|
Valneva SE
PA:VLA
|
$470.87 Million |
|
Daesang Corp
KO:001680
|
$470.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Model Organisms Center Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,736,783,386 to 1,683,000,520, a change of -53,782,866 (-3.1%).
- Net income of 6,495,504 contributed positively to equity growth.
- Dividend payments of 10,004,068 reduced retained earnings.
- Share repurchases of 47,707,671 reduced equity.
- Other comprehensive income increased equity by 14,239,097.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥6.50 Million | +0.39% |
| Dividends Paid | CN¥10.00 Million | -0.59% |
| Share Repurchases | CN¥47.71 Million | -2.83% |
| Other Comprehensive Income | CN¥14.24 Million | +0.85% |
| Other Changes | CN¥-16.81 Million | -1.0% |
| Total Change | CN¥- | -3.10% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Model Organisms Center Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.99x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.03x to 1.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | CN¥2.29 | CN¥41.30 | x |
| 2016-12-31 | CN¥7.72 | CN¥41.30 | x |
| 2017-12-31 | CN¥1.87 | CN¥41.30 | x |
| 2018-12-31 | CN¥2.13 | CN¥41.30 | x |
| 2019-12-31 | CN¥2.57 | CN¥41.30 | x |
| 2020-12-31 | CN¥4.46 | CN¥41.30 | x |
| 2021-12-31 | CN¥30.48 | CN¥41.30 | x |
| 2022-12-31 | CN¥22.89 | CN¥41.30 | x |
| 2023-12-31 | CN¥21.94 | CN¥41.30 | x |
| 2024-12-31 | CN¥20.73 | CN¥41.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Model Organisms Center Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.39%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.70%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.15x
- Recent ROE (0.39%) is below the historical average (7.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 17.47% | 23.34% | 0.41x | 1.83x | CN¥4.53 Million |
| 2016 | 19.42% | 24.16% | 0.40x | 2.00x | CN¥7.09 Million |
| 2017 | -16.55% | -21.04% | 0.43x | 1.84x | CN¥-25.75 Million |
| 2018 | 13.48% | 12.44% | 0.63x | 1.71x | CN¥3.90 Million |
| 2019 | 17.17% | 15.02% | 0.71x | 1.62x | CN¥9.71 Million |
| 2020 | 17.48% | 22.71% | 0.55x | 1.40x | CN¥19.06 Million |
| 2021 | 3.41% | 22.11% | 0.14x | 1.10x | CN¥-117.51 Million |
| 2022 | -0.31% | -1.78% | 0.15x | 1.16x | CN¥-181.99 Million |
| 2023 | -1.19% | -5.62% | 0.18x | 1.15x | CN¥-194.26 Million |
| 2024 | 0.39% | 1.70% | 0.20x | 1.15x | CN¥-161.80 Million |
Industry Comparison
This section compares Shanghai Model Organisms Center Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $6,387,359,426
- Average return on equity (ROE) among peers: 2.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Model Organisms Center Inc (688265) | CN¥1.70 Billion | 17.47% | 0.12x | $471.17 Million |
| Shenzhen CAU Technology Co Ltd (000004) | $948.24 Million | -53.63% | 0.17x | $53.47 Million |
| Pacific Shuanglin Bio pharmacy Co Ltd (000403) | $7.92 Billion | 9.41% | 0.17x | $1.63 Billion |
| Nanhua Bio Medicine Co Ltd (000504) | $304.67 Million | -9.25% | 1.53x | $444.78 Million |
| Jiangsu Sihuan Bioengineering Co Ltd (000518) | $1.06 Billion | 8.06% | 0.08x | $444.44 Million |
| Chengzhi Shareholding Co Ltd (000990) | $15.52 Billion | 0.71% | 0.30x | $2.24 Billion |
| Hualan Biological EngineeringInc (002007) | $6.88 Billion | 18.64% | 0.10x | $3.87 Billion |
| Da An Gene Co Ltd of Sun Yat-Sen University (002030) | $428.60 Million | 11.05% | 0.37x | $1.25 Billion |
| Shanghai RAAS Blood Products Co Ltd Class A (002252) | $29.65 Billion | 6.00% | 0.08x | $5.41 Billion |
| Baolingbao Biology Co Ltd (002286) | $703.11 Million | 6.09% | 0.47x | $568.58 Million |
| Tibet Cheezheng Tibetan Medicine Co Ltd (002287) | $456.61 Million | 23.20% | 0.29x | $1.91 Billion |
About Shanghai Model Organisms Center Inc
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, a… Read more